Park Ave Peptides — Clinical Reference Library — For Professional Use Only

For Licensed Physicians

Reference-Grade Peptides, Built Around the Way Physicians Actually Practice.

Documentation that holds up in chart review. NPI/DEA verification at account setup. A named clinical account manager who reads your protocol. No gray-market shortcuts.

HIPAA-aligned NPI/DEA verified EMR-ready docs

As referenced in

Practitioner Lab Podcast
Clinical Compounding Quarterly
Regenerative Medicine Review
Reference Industry Council

Practice ROI Calculator

Model Your Practice Economics

Drag the patient slider and pick a program to see projected monthly net, annualized revenue, and margin held against compound supply.

Choose a Program

Active Patients / Month

12

14080

Directional planning estimates only. Reflects average fees and compound supply costs reported by practices in the verified network. Actual results vary by protocol, geography, and patient mix.

Projected — Monthly

Patient Revenue

$28,800

Compound Supply

−$6,480

Net Margin

$22,320

78% margin held

Annualized Net

$267,840

For Verified Physician Accounts

What Comes With Every Account

EMR-Ready Documentation

Lot-specific COAs, prescriber records, and shipping logs formatted for chart retention and patient consent workflows.

Protocol Review Support

Editorial team available to review reference protocols, mechanism rationale, and combination considerations before first prescription.

NPI & DEA Verification

All accounts verified against active NPI and, where applicable, DEA registration on activation. No exceptions.

Prescriber-of-Record Workflow

Clear chain of clinical responsibility, signed informed-consent templates, and adverse-event reporting path documented per state.

Lot Traceability

Every shipment lot ID is logged against the prescribing clinician. Historical COAs retrievable for record retention or audit.

Net Terms & Bulk Pricing

Established practices may qualify for net-30 terms and tiered bulk pricing after initial order history.

Standard of Practice

How Park Ave Compares for Physicians

The capability set most physicians look for when vetting a compounding supplier.

Capability
Park Ave
Typical 503A
Gray-Market
Lot-specific COA per shipment
Named third-party analytical lab
Prescriber-of-record documentation
NPI / DEA verified at account setup
Product liability insurance on every lot
Cold-chain shipping with temperature log
Editorial review by licensed clinicians
Adverse-event support & lot retain samples
EMR-formatted documentation
Direct named account manager

Featured Practice

PA

Dr. Priya Anand, MD

Anand Endocrinology & Metabolic Health

Austin, TX

We moved our entire GLP-1 program to Park Ave after six months of vetting suppliers. The documentation alone — lot COAs, prescriber-of-record forms, adverse-event lot retains — saved my MA roughly four hours of chart prep per week. The clinical account manager knows our protocols by name.

Shared with permission

42

Active Patients on Program

$94k

Q1 Incremental Revenue

78%

Net Margin Held

4 hr/wk

Charting Time Recovered

Compliance & Liability FAQ

The Questions Physicians Ask First

Peptide compounding sits under state board of pharmacy and federal 503A/503B rules. Most states permit prescriber-ordered compounded therapies; specific compounds may be restricted. We confirm legality for your state during account verification and document the regulatory basis in writing.

For The Careful Prescriber

Questions A Careful Physician Asks

The hard questions a thoughtful prescriber asks before adding any compounded therapy to their practice. Answered plainly.

Where does the active pharmaceutical ingredient come from?

All APIs are sourced from FDA-registered manufacturers with documented chain of custody. Country of origin, manufacturer name, and inbound CoA are retained per lot and disclosed to verified accounts on request.

Is sterility testing performed on every lot, or by skip-lot?

Every released injectable lot undergoes USP <71> sterility and USP <85> endotoxin testing prior to release. No skip-lot testing. Results are tied to the lot ID on your shipment COA.

What happens if a compound is recalled mid-protocol?

Verified accounts receive direct notification within 24 hours of any recall affecting a lot you ordered. We provide replacement product from a cleared lot at no charge and supporting documentation for patient notification.

Who reports adverse events to MedWatch?

The prescribing physician submits MedWatch reports as the treating clinician. Park Ave provides lot retain samples, full analytical documentation, and pharmacovigilance support to assist your report and any subsequent investigation.

What is your stability data based on?

Beyond-use dating is established per USP <797> for sterile compounds and supported by accelerated and real-time stability data on representative formulations. Stability summaries are available to verified accounts.

How do you handle a failing lot?

A failed release test triggers full lot quarantine, root-cause investigation, and destruction under documented chain of custody. Failed lots never ship. CAPA records are retained for regulatory review.

Injectable Release Testing

Sterility & Endotoxin, Per Lot.

Every injectable peptide lot released by Park Ave is subjected to the full USP release panel before shipment. No exceptions, no skip-lot sampling, no “representative” testing across batches.

Lot-specific results are bound to your shipment COA. Retain samples are held through end of stability for any post-release investigation.

Test
Standard
Frequency
Sterility
USP <71>
Every released lot
Bacterial endotoxin
USP <85> (LAL)
Every released lot
Identity (HPLC / MS)
USP <621> / <736>
Every released lot
Assay & purity
HPLC ≥ 98.0%
Every released lot
Water content
USP <921> (Karl Fischer)
Every lyophilized lot
Particulate matter
USP <788>
Every parenteral lot
pH
USP <791>
Every solution lot
Container closure integrity
USP <1207>
Per validated frequency

State Compliance Matrix

Physician Compounding — By Jurisdiction

Compounding rules vary by state board of pharmacy. Below is a directional summary of common physician-ordering requirements. We confirm your specific state during account verification.

State Group
Patient-Specific Rx
Office Use Allowed
Out-of-State Ship
TX, FL, AZ, NV, CO
Required
Limited / restricted
Permitted with NR
CA
Required
Restricted
Permitted with NR
NY, NJ, CT, MA
Required
Limited
Permitted with NR
IL, OH, MI, PA
Required
Allowed (small qty)
Permitted with NR
GA, NC, SC, TN
Required
Allowed (small qty)
Permitted with NR
WA, OR
Required
Limited
Permitted with NR
Other states
Required
Confirm during verification
Confirm during verification

Directional summary only. “NR” = non-resident pharmacy registration in the receiving state, which Park Ave maintains in all states where required. Final compliance posture is confirmed in writing during account verification for your specific license and practice location.

If Something Goes Wrong

Adverse Event Reporting Workflow

The exact sequence that runs when a verified physician account reports a suspected adverse event. Documented, named, and timed.

Step 01

Direct Line, Same Day

Physician calls the named clinical account manager — direct mobile, not a call center. Initial intake within the same business day. After-hours line for urgent events.

Step 02

Lot Retrieval, ≤ 4 hr

Lot ID, COA, retain sample, batch records, and sterility/endotoxin data pulled and packaged for the prescribing physician within 4 business hours.

Step 03

Documentation Support

We provide a structured event summary the physician can attach to the patient chart and the MedWatch 3500 if a report is submitted. Physician remains the reporter.

Step 04

Investigation & CAPA

Internal investigation opens within 24 hours. Root-cause analysis, retain re-testing, and any corrective/preventive action are documented and shared back with the reporting physician.

Park Ave never replaces the prescriber-of-record relationship.

Your patient remains your patient. We supply the documentation, the lot evidence, and the clinical support — the medical decisions remain yours.

Request AE Protocol

Direct Clinician Access

Book a 15-Min Clinical Protocol Call

Pick a time. A clinical account manager reviews your protocol, documentation needs, and account terms. No call center, no sales pitch.